Cargando...
Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis
OBJECTIVE: To examine whether rituximab induction followed by glatiramer acetate (GA) monotherapy is more effective than GA alone for the treatment of relapsing multiple sclerosis with active disease. METHODS: This was a single-center, double-blind, placebo-controlled study. Fifty-five participants...
Guardado en:
| Publicado en: | Neurology |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6382366/ https://ncbi.nlm.nih.gov/pubmed/30635477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000006916 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|